Cigna Corp. (CI) News
Filter CI News Items
CI News Results
|Loading, please wait...|
CI News Highlights
- CI's 30 day story count now stands at 16.
- Over the past 26 days, the trend for CI's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- DRUG, HUM and BASE are the most mentioned tickers in articles about CI.
Latest CI News From Around the Web
Below are the latest news stories about CIGNA GROUP that investors may wish to consider to help them evaluate CI as an investment opportunity.
Implied Volatility Surging for Cigna Group (CI) Stock Options
Investors need to pay close attention to Cigna Group (CI) stock based on the movements in the options market lately.
15 Cheap Beginner Stocks to Buy
In this article, we will take a look at 15 cheap stocks to buy now for beginners. If you want to explore similar stocks, you can also take a look at 5 Cheap Beginner Stocks to Buy. Morgan Stanley’s Big Bear: “It’s Just A Much Less Predictable World” On March 27 Morgan Stanley’s chief U.S. […]
Dreaded Medical Paperwork Required by Health Insurers to Be Trimmed
Prior authorization has generated so much resentment in recent years that some health insurers have been making tweaks.
Here's Why Investors Should Retain Cigna (CI) Stock Now
Cigna (CI) remains well-poised for growth on the back of continually growing premiums within its Cigna Healthcare unit. Solid cash-generating abilities also enable it to deploy capital.
Here is What to Know Beyond Why Cigna Group (CI) is a Trending Stock
Zacks.com users have recently been watching Cigna (CI) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Cigna (CI) Outpaces Stock Market Gains: What You Should Know
Cigna (CI) closed the most recent trading day at $261.78, moving +0.6% from the previous trading session.
Does Big Pharmacy Managers Fix Prices? Ohio Attorney General Lawsuit Alleges Cigna, Humana Engaged In Price Fixing For Medicines
A lawsuit filed by the Ohio attorney general alleges that Cigna Corp (NYSE: CI), Humana Inc (NYSE: HUM), and Prime Therapeutics LLC shared pricing and other information to gain leverage during negotiations for rebates. The lawsuit comes as some policymakers explore the healthcare companies' role in high-cost drugs, Wall Street Journal reported. The Federal Trade Commission, House Republicans, and several states have launched investigations into pharmacy-benefit managers (PBMs). Governments, empl
Drug Middlemen Accused of Price Fixing by Ohio Attorney General
The state’s lawsuit alleged certain pharmacy-benefit managers shared drug pricing and other information to gain leverage during rebate negotiations with pharmaceutical companies.
UPDATE 3-Cigna's PBM, two others sued in Ohio over drug price fixing
accusing Cigna Group, Humana Inc and others of colluding to drive up prescription drug prices by charging exorbitant fees for pharmacy benefit management services. regulators of pharmacy benefit managers (PBMs) like Cigna's Express Scripts unit, which is named as a defendant.
Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare
UnitedHealth, The Cigna, Humana, Centene and Molina Healthcare are part of the Zacks Industry Outlook article.